| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Outline of Final Research Achievements |
Many papers have shown that diabetes patients are associated with cancer risk. In addition, the highest mortality of diabetes is cancer. However how diabetes increases the risk has not been well understood.
In this study we demonstrated glucagon receptor expressed some human colon cancer tissues, human colon cancer cell lines and mouse colon cancer cell lines. Glucagon promoted cell growth via AMP-activated protein kinase and mitogen-activated protein kinase.
|
